One PR could send the share price past .50 cents or

New Post Public Reply Private Reply Replies (0) Message Board
joey68
One PR could send the share price past .50 cents or higher.

How do I know this? It happened before.

Anyone remember the 2009 spike?

On September 16, 2009 we received a PR stating Spectrascience received FDA approval and on the same day SCIE opened at .35 cents and had a high of $1.76.

http://www.prnewswire.com/news-releases/spect...93892.html

That's $1.41 change in 8 hours . Of course, the price went back down to average levels the next day, but could you image if someone had a sell order in for $1.30?

Not investment advice. Do NOT base your investments on this or any post. Talk to an investment professional before and during all investments.

See image below
Link if you cant see image
http://i.imgur.com/y5FTGUR.png

y5FTGUR.png

This is why I have my sell orders in place because, although I believe SCIE will slowly and naturally progress upward in price, we never know if a spike like this will occur again, and seeing it has happened in the past, I want to be prepared in case it happens again.

Obviously, just because it happened in the past doesn't mean it will definitely happen again; but it shows me that there is interest in this stock and that investors are waiting on the sideline for the right news.

Not investment advice. Do NOT base your investments on this or any post. Talk to an investment professional before and during all investments.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Freeport-McMoRan Hit with Legal Probe: What's Next?

Updated Category News Views 4

Investigating the Movers and Shakers at Freeport When legal hawks like Kahn Swick & Foti, LLC sink their teeth into something, you can bet it's not just to nibble. These folks have jumped headfirst into probing Freeport-McMoRan Inc. (NYSE:FCX), ready to dismantle any smoke screens that might have been thrown up after the unfortunate Grasberg Block Cave mine incident. The...

Continue Reading
Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 5

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
BMO Sheds U.S. Branches, Eyes Strategic Growth

Updated Category News Views 1

Why BMO is Slimming Down in the States You know, when a heavyweight like BMO Financial Group starts shedding branches left and right, you gotta ask yourself what the grand plan is. In a move that looks more like a strategic dance than an abrupt U-turn, BMO's gotten rid of 138 U.S. branches, handing them over to First-Citizens Bank. We're talking outlets scattered from...

Continue Reading
Pudu Robotics Showcases Expansive Portfolio at IFA 2026

Updated Category News Views 2

Robotics in the Spotlight: Pudu's Grand European Entry Well, you don't see this every day—Pudu Robotics, a name riding high in the robotics sphere, is strutting its stuff over at IFA 2026 in Berlin. This ain't just a teaser, folks. They're unloading the whole toolkit, diving head-first into the European market. From gears turning in service delivery bots to industrial...

Continue Reading
Hisense Showcases AI in Everyday Living at IFA 2026

Updated Category News Views 4

Hisense's Vision: An AI Utopia for Home Take this in: Hisense is cooking something bold at IFA 2026. They're pushing the envelope by integrating AI into our daily grind, promising to change the way we interact with the spaces that matter most. No more just dreaming about futuristic homes—these guys seem dead set on making them our everyday reality. Connected...

Continue Reading
Dr. Rashedi Reveals Laughing Gas Safety for Kids

Updated Category News Views 3

Why Laughing Gas is a Game-Changer in Pediatric Dentistry You ever seen a kid freeze up like a deer in headlights at the dentist's office? I'm telling you, it's not just the sweet tooth nightmare but often the fear of that cold, intimidating chair. But let's talk about a game-changer: laughing gas or, known in the trade as nitrous oxide. Keeping Anxiety at Bay: The Role...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 1

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
Carles Puyol Joins Midea at IFA 2026, Celebrating Unity

Updated Category News Views 2

Leadership, Innovation, and Soccer Collide in Berlin When you’ve got a Barcelona legend like Carles Puyol gracing an event, it's more than just fanfare. This time around, Puyol made waves at Midea's stand during IFA 2026 in Berlin, signaling a strategic power move for both Midea and FC Barcelona. We're talking about a scene where tech innovation meets world-class...

Continue Reading
Penetron Strengthens Midwest, Central USA Support Team

Updated Category News Views 3

Expansion of Penetron's Engineering Support Eyes are on the Midwest and Central USA as Penetron makes a strategic move to bolster their technical support dream team. They've snagged Sean Allison, a heavyweight with more than three decades' worth of grit and know-how from the construction battlefield. Sean, now stationed in the heart of America's Dairyland—Green Bay,...

Continue Reading
Auto Maintenance: Key Tips for Long-Term Vehicle Health

Updated Category News Views 2

Beating Breakdown Blues: Preventative Maintenance Insights You ever look under the hood and wonder what's ticking away? Cars ain't just about turning keys and hitting gas—there's a beating heart under all that metal and rubber. That's what HelloNation's serving us here, with David Mantz and his kid, David Mantz Jr., lifting the lid on preventative maintenance. These...

Continue Reading

Top 5 Most Recently Viewed Articles

Cliff Lede Vineyards Partners with Springboard for Distribution

Updated Category News Views 152

Cliff Lede Vineyards Announces New Distribution Partnership Cliff Lede Vineyards, a family-owned winery recognized for its quality wines, recently shared exciting news about collaborating with Springboard Wine & Spirits Company, which will serve as its broker for distribution throughout California. This partnership marks a strategic move to enhance the visibility and...

Continue Reading
Apollo's Vision for Growth: Investor Day Insights Unveiled

Updated Category News Views 151

Apollo (NYSE: APO) laid out a bold growth strategy back in 2024 during its Investor Day, aiming to reshape the landscape of alternative asset management. Investors were buzzing as the firm showcased not just its financial goals but also insights into market dynamics and operational tactics. CEO Insights: Market Confidence or Overreach? Marc Rowan, Apollo's CEO, delivered...

Continue Reading
CreateAI Emerges from TuSimple as a Gaming AI Innovator

Updated Category News Views 405

CreateAI Transitions from Autonomous Driving to AI Gaming TuSimple Holdings Inc. has officially rebranded itself as CreateAI, showcasing a remarkable transformation from a company focused on autonomous driving technology to one dedicated to the development of AI-powered gaming and content creation. This strategic shift illustrates CreateAI's commitment to harnessing...

Continue Reading
XPO's Impressive Q3 2024 Performance: A Closer Look

Updated Category News Views 102

XPO's Financial Results for Third Quarter XPO (NYSE: XPO) has made significant strides in its financial performance, recently announcing its Q3 outcomes which reflect resilience in a challenging freight market. The company reported diluted earnings from continuing operations at $0.79 per share, a notable increase compared to last year's $0.72. Meanwhile, adjusted diluted...

Continue Reading
Lantheus Holdings Faces Class Action Lawsuit Amid Stock Decline

Updated Category News Views 162

Lantheus Holdings Faces Class Action Lawsuit Pomerantz LLP has announced that a class action lawsuit has been filed against Lantheus Holdings, Inc. (NASDAQ: LNTH). This action targets investors who may have suffered losses and encourages those impacted to seek assistance. The Nature of the Class Action The lawsuit challenges allegations of securities fraud involving...

Continue Reading